Cancer-Specific requirement for BUB1B/BUBR1 in human brain tumor isolates and genetically transformed cells.

UNLABELLED To identify new candidate therapeutic targets for glioblastoma multiforme, we combined functional genetics and glioblastoma network modeling to identify kinases required for the growth of patient-derived brain tumor-initiating cells (BTIC) but that are dispensable to proliferating human neural stem cells (NSC). This approach yielded BUB1B/BUBR1, a critical mitotic spindle checkpoint player, as the top-scoring glioblastoma lethal kinase. Knockdown of BUB1B inhibited expansion of BTIC isolates, both in vitro and in vivo, without affecting proliferation of NSCs or astrocytes. Mechanistic studies revealed that BUB1B's GLE2p-binding sequence (GLEBS) domain activity is required to suppress lethal kinetochore-microtubule (KT-MT) attachment defects in glioblastoma isolates and genetically transformed cells with altered sister KT dynamics, which likely favor KT-MT instability. These results indicate that glioblastoma tumors have an added requirement for BUB1B to suppress lethal consequences of altered KT function and further suggest that sister KT measurements may predict cancer-specific sensitivity to BUB1B inhibition and perhaps other mitotic targets that affect KT-MT stability. SIGNIFICANCE Currently, no effective therapies are available for glioblastoma, the most frequent and aggressive brain tumor. Our results suggest that targeting the GLEBS domain activity of BUB1B may provide a therapeutic window for glioblastoma, as the GLEBS domain is nonessential in untransformed cells. Moreover, the results further suggest that sister KT distances at metaphase may predict sensitivity to anticancer therapeutics targeting KT function.

[1]  E. Salmon,et al.  The spindle-assembly checkpoint in space and time , 2007, Nature Reviews Molecular Cell Biology.

[2]  Joshua M. Korn,et al.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.

[3]  Keith F. DeLuca,et al.  Temporal changes in Hec1 phosphorylation control kinetochore–microtubule attachment stability during mitosis , 2011, Journal of Cell Science.

[4]  Rachel B. Brem,et al.  Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks , 2008, Nature Genetics.

[5]  D. Rowitch,et al.  Glioma Stem Cells: A Midterm Exam , 2008, Neuron.

[6]  K. Aldape,et al.  Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma. , 2001, Cancer research.

[7]  R. Mirimanoff,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[8]  Mark W. Dewhirst,et al.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.

[9]  S. Gabriel,et al.  Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.

[10]  L. Hartwell,et al.  Integrating genetic approaches into the discovery of anticancer drugs. , 1997, Science.

[11]  Tao Xie,et al.  Inferring causal genomic alterations in breast cancer using gene expression data , 2011, BMC Systems Biology.

[12]  R. Medema,et al.  Shared and separate functions of polo-like kinases and aurora kinases in cancer , 2010, Nature Reviews Cancer.

[13]  Qiulian Wu,et al.  Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. , 2006, Cancer research.

[14]  A. Musacchio,et al.  The life and miracles of kinetochores , 2009, The EMBO journal.

[15]  J. Uhm.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2009 .

[16]  G. Parkin,et al.  Long-term tripotent differentiation capacity of human neural stem (NS) cells in adherent culture , 2008, Molecular and Cellular Neuroscience.

[17]  S. Nelson,et al.  Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors , 2009, Journal of Neuro-Oncology.

[18]  F. DiMeco,et al.  Erratum: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma (Cancer Research (October 2004) 64 (7011-7021) , 2004 .

[19]  Ju-Hyung Woo,et al.  Increased Expression of Mitotic Checkpoint Genes in Breast Cancer Cells with Chromosomal Instability , 2006, Clinical Cancer Research.

[20]  Mark Bernstein,et al.  Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. , 2009, Cell stem cell.

[21]  Daniel H. Geschwind,et al.  Cancerous stem cells can arise from pediatric brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Catling,et al.  Active MAP Kinase in Mitosis: Localization at Kinetochores and Association with the Motor Protein CENP-E , 1998, The Journal of cell biology.

[23]  T. Yen,et al.  Targeting Mitosis for Anti-Cancer Therapy , 2012, BioDrugs.

[24]  K. Takagaki,et al.  Kinetochore stretching inactivates the spindle assembly checkpoint , 2009, The Journal of cell biology.

[25]  R. Goorha,et al.  Spindle checkpoint function requires Mad2-dependent Cdc20 binding to the Mad3 homology domain of BubR1. , 2006, Experimental cell research.

[26]  G. Neale,et al.  The mitotic checkpoint gene BubR1 has two distinct functions in mitosis. , 2005, Experimental cell research.

[27]  J. V. van Deursen,et al.  BubR1 N terminus acts as a soluble inhibitor of cyclin B degradation by APC/C(Cdc20) in interphase. , 2009, Developmental cell.

[28]  Z. Darżynkiewicz,et al.  BUBR1 deficiency results in abnormal megakaryopoiesis. , 2003, Blood.

[29]  A. Desai,et al.  Microtubule capture by CENP-E silences BubR1-dependent mitotic checkpoint signaling , 2005, The Journal of cell biology.

[30]  Hongtao Yu,et al.  Mad2-Independent inhibition of APCCdc20 by the mitotic checkpoint protein BubR1. , 2001, Developmental cell.

[31]  Ugo Orfanelli,et al.  Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma , 2004, Cancer Research.

[32]  Timothy J. Mitchison,et al.  Mitotic spindle organization by a plus-end-directed microtubule motor , 1992, Nature.

[33]  E. Nigg,et al.  Uncoupling of the spindle-checkpoint and chromosome-congression functions of BubR1 , 2010, Journal of Cell Science.

[34]  Neysa Nevins,et al.  Antitumor activity of an allosteric inhibitor of centromere-associated protein-E , 2010, Proceedings of the National Academy of Sciences.

[35]  T. Kapoor,et al.  The human mitotic checkpoint protein BubR1 regulates chromosome–spindle attachments , 2005, Nature Cell Biology.

[36]  T. Mitchison,et al.  Spindle Assembly in the Absence of a RanGTP Gradient Requires Localized CPC Activity , 2009, Current Biology.

[37]  Michael J. Emanuele,et al.  A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras Oncogene , 2009, Cell.

[38]  E. Gabrielson,et al.  Yuan B, Xu Y, Woo JH, Wang Y, Bae YK, Yoon DS et al.. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin Cancer Res 12: 405-410 , 2006 .

[39]  Deric M. Park,et al.  Biology of glioma cancer stem cells , 2009, Molecules and cells.

[40]  Nina M. Muñoz,et al.  Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. , 2007, Cancer research.

[41]  Andrea Musacchio,et al.  Kinetochore Microtubule Dynamics and Attachment Stability Are Regulated by Hec1 , 2006, Cell.

[42]  Xianshu Wang,et al.  The Mitotic Checkpoint Protein hBUB3 and the mRNA Export Factor hRAE1 Interact with GLE2p-binding Sequence (GLEBS)-containing Proteins* , 2001, The Journal of Biological Chemistry.

[43]  N. Macleod.  Figure 3.1 , 2007 .

[44]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[45]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[46]  E. Salmon,et al.  hNuf2 inhibition blocks stable kinetochore–microtubule attachment and induces mitotic cell death in HeLa cells , 2002, The Journal of cell biology.

[47]  Bert Vogelstein,et al.  Mutations of mitotic checkpoint genes in human cancers , 1998, Nature.

[48]  H. Fine,et al.  SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. , 2009, Cell stem cell.

[49]  T. Yen,et al.  Mitotic regulation of microtubule cross-linking activity of CENP-E kinetochore protein. , 1994, Science.

[50]  M. McClelland,et al.  The Accuracy of Survival Time Prediction for Patients with Glioma Is Improved by Measuring Mitotic Spindle Checkpoint Gene Expression , 2011, PloS one.

[51]  Yuri Kotliarov,et al.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. , 2006, Cancer cell.

[52]  Ben S. Wittner,et al.  Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1 , 2009, Nature.